114 related articles for article (PubMed ID: 2937532)
21. The effect of progesterone and synthetic progestins on serum- and estradiol-stimulated proliferation of human breast cancer cells.
Seeger H; Wallwiener D; Mueck AO
Horm Metab Res; 2003 Feb; 35(2):76-80. PubMed ID: 12734785
[TBL] [Abstract][Full Text] [Related]
22. Effect of medroxyprogesterone acetate on proliferation and cell cycle kinetics of human mammary carcinoma cells.
Sutherland RL; Hall RE; Pang GY; Musgrove EA; Clarke CL
Cancer Res; 1988 Sep; 48(18):5084-91. PubMed ID: 2970295
[TBL] [Abstract][Full Text] [Related]
23. Comparison of norethindrone and medroxyprogesterone acetate with natural progesterone and estradiol in stimulating prolactin production from cultured endometrial stromal cells.
Levin JH; Tonetta SA; Lobo RA
Am J Obstet Gynecol; 1990 Dec; 163(6 Pt 1):1932-8. PubMed ID: 2147816
[TBL] [Abstract][Full Text] [Related]
24. Randomized trial comparing aminoglutethimide with high-dose medroxyprogesterone acetate in therapy for advanced breast carcinoma.
Canney PA; Priestman TJ; Griffiths T; Latief TN; Mould JJ; Spooner D
J Natl Cancer Inst; 1988 Sep; 80(14):1147-51. PubMed ID: 2970555
[TBL] [Abstract][Full Text] [Related]
25. Modulation of lactogenic receptors by progestins in cultured human breast cancer cells.
Murphy LJ; Murphy LC; Stead B; Sutherland RL; Lazarus L
J Clin Endocrinol Metab; 1986 Feb; 62(2):280-7. PubMed ID: 3001123
[TBL] [Abstract][Full Text] [Related]
26. Direct antiproliferative effect of triptorelin on human breast cancer cells.
Marini L; Iacopino F; Schinzari G; Robustelli della Cuna FS; Mantovani G; Sica G
Anticancer Res; 1994; 14(5A):1881-5. PubMed ID: 7847821
[TBL] [Abstract][Full Text] [Related]
27. Growth inhibitory effect of LH-RH analogs on human breast cancer cells.
Scambia G; Panici PB; Baiocchi G; Perrone L; Gaggini C; Iacobelli S; Mancuso S
Anticancer Res; 1988; 8(1):187-90. PubMed ID: 2965864
[TBL] [Abstract][Full Text] [Related]
28. [Breast cancer and hormone therapy].
Izuo M
Gan To Kagaku Ryoho; 1987 Oct; 14(10):2830-6. PubMed ID: 2959203
[TBL] [Abstract][Full Text] [Related]
29. Effects of different progestogens on human breast tumor cell growth.
Chen FP; Chien MH; Chen HY; Ng YT
Climacteric; 2011 Jun; 14(3):345-51. PubMed ID: 21375453
[TBL] [Abstract][Full Text] [Related]
30. The anti-proliferative effect of suramin towards tamoxifen-sensitive and resistant human breast cancer cell lines in relation to expression of receptors for epidermal growth factor and insulin-like growth factor-I: growth stimulation in the presence of tamoxifen.
Boylan M; van den Berg HW; Lynch M
Ann Oncol; 1998 Feb; 9(2):205-11. PubMed ID: 9553667
[TBL] [Abstract][Full Text] [Related]
31. The human squamous cervical carcinoma cell line, HOG-1, is responsive to steroid hormones.
White JO; Jones RN; Croxtall JD; Gleeson RP; Krausz T; Pervez S; Jamil A; Guida L; Beesley JE; Soutter WP
Int J Cancer; 1992 Sep; 52(2):247-51. PubMed ID: 1387868
[TBL] [Abstract][Full Text] [Related]
32. Medroxyprogesterone acetate versus tamoxifen in the therapy of advanced breast cancer.
Lorenz I; Mechl Z
Neoplasma; 1985; 32(1):119-24. PubMed ID: 3157070
[TBL] [Abstract][Full Text] [Related]
33. [Which hormone therapy should be used in advanced breast carcinoma in males?].
Lönning PE; Wiedemann G; Kvinnsland S; Lundgren S
Dtsch Med Wochenschr; 1988 Sep; 113(35):1358-61. PubMed ID: 2970379
[TBL] [Abstract][Full Text] [Related]
34. Hormone therapy in advanced breast cancer: high dose medroxyprogesterone acetate (MAP) vs tamoxifen (TMX). Preliminary results.
Pannuti F; Martoni A; Fruet F; Strocchi E; Di Marco AR
Eur J Cancer (1965); 1980; Suppl 1():93-8. PubMed ID: 6459237
[No Abstract] [Full Text] [Related]
35. Growth stimulation and differential regulation of transforming growth factor-beta 1 (TGF beta 1), TGF beta 2, and TGF beta 3 messenger RNA levels by norethindrone in MCF-7 human breast cancer cells.
Jeng MH; Jordan VC
Mol Endocrinol; 1991 Aug; 5(8):1120-8. PubMed ID: 1834933
[TBL] [Abstract][Full Text] [Related]
36. Estrogen and progesterone receptors in the endometrium of postmenopausal breast cancer patients treated with tamoxifen and progestogens.
Cohen I; Altaras MM; Beyth Y; Shapira J; Figer A; Tepper R; Cordoba M; Yigal D; Bernheim J
Gynecol Oncol; 1997 Apr; 65(1):83-8. PubMed ID: 9103396
[TBL] [Abstract][Full Text] [Related]
37. The effects of progesterone, medroxyprogesterone acetate, and norethisterone on growth factor- and estradiol-treated human cancerous and noncancerous breast cells.
Krämer EA; Seeger H; Krämer B; Wallwiener D; Mueck AO
Menopause; 2005; 12(4):468-74. PubMed ID: 16037763
[TBL] [Abstract][Full Text] [Related]
38. Effect of 17 beta-estradiol, progesterone, synthetic progestins, tibolone, and tibolone metabolites on vascular endothelial growth factor mRNA in breast cancer cells.
Mirkin S; Wong BC; Archer DF
Fertil Steril; 2005 Aug; 84(2):485-91. PubMed ID: 16084894
[TBL] [Abstract][Full Text] [Related]
39. Effects of tamoxifen, medroxyprogesterone acetate and estradiol on tumor growth and oncogene expression in MCF-7 breast cancer cell line transplanted into nude mice.
Mizukami Y; Tajiri K; Nonomura A; Noguchi M; Taniya T; Koyasaki N; Nakamura S; Matsubara F
Anticancer Res; 1991; 11(3):1333-8. PubMed ID: 1832273
[TBL] [Abstract][Full Text] [Related]
40. Oral high-dose medroxyprogesterone acetate versus tamoxifen. A randomized crossover trial in postmenopausal patients with advanced breast cancer.
van Veelen H; Willemse PH; Tjabbes T; Schweitzer MJ; Sleijfer DT
Cancer; 1986 Jul; 58(1):7-13. PubMed ID: 2939943
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
